FindTrial
Sign In

MODY gene mutations in females with Diabetes in Pregnancy

Identification of MODY2 gene mutations and its clinical correlation with gestational diabetes in India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/07/008964
Enrollment
500
Registered
2017-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Gestational Diabetes Mellitus & Control

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pregnant females of age >18 years 2.Females with fasting glucose levels of >=92 mg/dl or 3.Females knowing their pre-pregnancy weight 4.Pregnant females who are ready to participate in the study, follow-up and provide informed consent

Exclusion criteria

Exclusion criteria: 1.Females diagnosed with diabetes. 2.Females unwilling for follow-up or to give informed consent.

Design outcomes

Primary

MeasureTime frame
Primary Outcome: â?¢GCK variants associated with diabetes or gestational diabetes â?¢CRP & IL-6 levels raised in GDM subjects as compared to non-GDM Timepoint: July 2018—

Secondary

MeasureTime frame
Secondary Outcome: â?¢10% incidence of gestational diabetes. â?¢Macrosomic baby (3.5 Kg) in females with gestational diabetes.Timepoint: July 2018—

Countries

India

Contacts

Public ContactSamreen Siddiqui

Max Healthcare Inst Ltd & Amity Institute of Virology & Immunology

sid.samreen@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 25, 2026